Drug intelligence / Profile preview

225Ac-PSMA-VG-01

Development stage: Preclinical
Lead developer: VitsGen Therapeutics
Modality: Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration: Intravenous

Overview

225Ac-PSMA-VG-01 is a preclinical-stage radionuclide drug conjugate (RDC) developed by VitsGen Therapeutics for the treatment of prostate cancer. The therapeutic agent targets prostate-specific membrane antigen (PSMA), a protein highly expressed on the surface of prostate cancer cells. It utilizes the alpha-emitting radioisotope Actinium-225 (225Ac) to deliver high-energy radiation directly to tumor cells, inducing double-strand DNA breaks and cell death while sparing adjacent healthy tissue. The program is currently in the preclinical phase, with an Investigational New Drug (IND) filing targeted for late 2024 and clinical trials expected to commence in mid-2025.

Other names: Actinium-225 PSMA-VG-01Actinium225 PSMA-VG-01Actinium 225 PSMA-VG-01

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on 225Ac-PSMA-VG-01.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 225Ac-PSMA-VG-01.

Explore the full profile